120 related articles for article (PubMed ID: 22833856)
1. Recognition based hormonal 95kDa monoclonal antibody on three human cancer cell lines for developing targeted radio-immuno-imaging and therapy.
Bandopadhyaya GP; Arora G; Shukla J; Ghosh S
Hell J Nucl Med; 2012; 15(2):108-13. PubMed ID: 22833856
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cytotoxic and tumor targeting capability of (177)Lu-DOTATATE-nanoparticles: a trailblazing strategy in peptide receptor radionuclide therapy.
Arora G; Dubey P; Shukla J; Ghosh S; Bandopadhyaya G
Ann Nucl Med; 2016 Jun; 30(5):334-45. PubMed ID: 26897009
[TBL] [Abstract][Full Text] [Related]
3. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
[TBL] [Abstract][Full Text] [Related]
4. Diabody Pretargeting with Click Chemistry In Vivo.
van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
[TBL] [Abstract][Full Text] [Related]
6. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
[TBL] [Abstract][Full Text] [Related]
7. Preparation and biological evaluation of (177)Lu conjugated PR81 for radioimmunotherapy of breast cancer.
Salouti M; Babaei MH; Rajabi H; Rasaee Mj
Nucl Med Biol; 2011 Aug; 38(6):849-55. PubMed ID: 21843781
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin beta.
Yu N; Xu W; Jiang Z; Cao Q; Chu Y; Xiong S
Immunol Lett; 2007 Dec; 114(2):94-102. PubMed ID: 17964664
[TBL] [Abstract][Full Text] [Related]
9. Purification of three major forms of beta-hCG from urine and production of polyclonal antibodies against them.
Khademi F; Hamzehee K; Mostafaie A; Hajihossaini R
Clin Biochem; 2009 Sep; 42(13-14):1476-82. PubMed ID: 19501580
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
[TBL] [Abstract][Full Text] [Related]
11. 131I-labeled monoclonal antibody targeting neuropilin receptor type-2 for tumor SPECT imaging.
Chen L; Wang L; Yan J; Ma C; Lu J; Chen G; Chen S; Su F; Wang W; Su X
Int J Oncol; 2017 Feb; 50(2):649-659. PubMed ID: 28000859
[TBL] [Abstract][Full Text] [Related]
12. Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers.
Yan H; Kapoor V; Nguyen K; Akers WJ; Li H; Scott J; Laforest R; Rogers B; Thotala D; Hallahan D
Oncotarget; 2016 Jul; 7(28):43352-43362. PubMed ID: 27270318
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of monoclonal antibody localization in subcutaneous and intracranial lung tumor xenografts after proton irradiation.
Gridley DS; Smith TE; Liwnicz BH; McMillan PJ
Anticancer Res; 1994; 14(6B):2493-500. PubMed ID: 7872672
[TBL] [Abstract][Full Text] [Related]
14. CD38 as a PET Imaging Target in Lung Cancer.
Ehlerding EB; England CG; Jiang D; Graves SA; Kang L; Lacognata S; Barnhart TE; Cai W
Mol Pharm; 2017 Jul; 14(7):2400-2406. PubMed ID: 28573863
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach.
Stipsanelli E; Valsamaki P
Hell J Nucl Med; 2005; 8(2):103-8. PubMed ID: 16142251
[TBL] [Abstract][Full Text] [Related]
16. Tumor pretargeting for radioimmunodetection and radioimmunotherapy.
Zhu H; Jain RK; Baxter LT
J Nucl Med; 1998 Jan; 39(1):65-76. PubMed ID: 9443740
[TBL] [Abstract][Full Text] [Related]
17. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.
Goldenberg DM; Sharkey RM; Paganelli G; Barbet J; Chatal JF
J Clin Oncol; 2006 Feb; 24(5):823-34. PubMed ID: 16380412
[TBL] [Abstract][Full Text] [Related]
18. Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
Schoffelen R; van der Graaf WT; Sharkey RM; Franssen GM; McBride WJ; Chang CH; Bos DL; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2012 Dec; 53(12):1926-32. PubMed ID: 23081995
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors.
Vera DR; Eigner S; Beran M; Henke KE; Laznickova A; Laznicek M; Melichar F; Chinol M
Cancer Biother Radiopharm; 2011 Jun; 26(3):287-97. PubMed ID: 21711096
[TBL] [Abstract][Full Text] [Related]
20. Magnetic particle-linked anti hCG β antibody for immunoassay of human chorionic gonadotropin (hCG), potential application to early pregnancy diagnosis.
Kuo HT; Yeh JZ; Jiang CM; Wu MC
J Immunol Methods; 2012 Jul; 381(1-2):32-40. PubMed ID: 22542932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
